Of 155 patients, three had pathogenic mutations in ATM, MRE11A, or MSH6. These results suggested individuals carrying germline mutations in DNA repair genes were at risk of breast or ovarian cancer. The gene discussed is MSH6; the disease is ovarian carcinoma.